Literature DB >> 16060710

Manifestations of cutaneous diabetic microangiopathy.

Binh T Ngo1, Kristie D Hayes, Dominick J DiMiao, Shashi K Srinivasan, Christopher J Huerter, Marc S Rendell.   

Abstract

The etiologies of a variety of skin conditions associated with diabetes have not been fully explained. One possible etiological factor is diabetic microangiopathy, which is known to affect the eyes and kidneys in patients with diabetes. There are many mechanisms by which diabetes may cause microangiopathy. These include excess sorbitol formation, increased glycation end products, oxidative damage, and protein kinase C overactivity. All of these processes occur in the skin, and the existence of a cutaneous diabetic microangiopathy has been well demonstrated. These microangiopathic changes are associated with abnormalities of skin perfusion. Because the skin plays a thermoregulatory role, there is significant capillary redundancy in normal skin. In diabetic patients, loss of capillaries is associated with a decrease in perfusion reserve. This lost reserve is demonstrable under stressed conditions, such as thermal stimulation. The associated failure of microvascular perfusion to meet the requirements of skin metabolism may result in diverse skin lesions in patients with diabetes. Many skin conditions peculiar to diabetes are fairly rare. Necrobiosis lipoidica diabeticorum (NLD) and diabetic bullae occur very infrequently as compared with diabetic retinopathy and nephropathy. Conversely, there is a correlation between diabetic microvascular disease and NLD. This correlation also exists with more common skin conditions, such as diabetic dermopathy. This relationship suggests that diabetic microangiopathy may contribute to these conditions even if it is not primarily causal. Clinically, the major significance of diabetic cutaneous microangiopathy is seen in skin ulceration which is very common and has a major impact on diabetic patients. Many factors contribute to the development of diabetic foot ulcers. Neuropathy, decreased large vessel perfusion, increased susceptibility to infection, and altered biomechanics all play a role, but there is no doubt that inadequate small blood vessel perfusion is a major cause of the inability to heal small wounds that eventually results in ulcer formation. The accessibility of skin capillaries makes cutaneous diabetic microangiopathy an attractive model for research on the evolution of microvascular disease in diabetic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16060710     DOI: 10.2165/00128071-200506040-00003

Source DB:  PubMed          Journal:  Am J Clin Dermatol        ISSN: 1175-0561            Impact factor:   7.403


  24 in total

1.  Cutaneous sarcoidosis clinically mimicking necrobiosis lipoidica in a patient with systemic sarcoidosis.

Authors:  Takahito Chiba; Masakazu Takahara; Takeshi Nakahara; Shuji Fukagawa; Kenjiro Takei; Asuka Shono; Hiromaro Kiryu; Yoichi Moroi; Masutaka Furue
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

2.  Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome.

Authors:  T Benfield; J S Jensen; B G Nordestgaard
Journal:  Diabetologia       Date:  2006-12-23       Impact factor: 10.122

3.  In vivo laser speckle imaging reveals microvascular remodeling and hemodynamic changes during wound healing angiogenesis.

Authors:  Abhishek Rege; Nitish V Thakor; Kevin Rhie; Arvind P Pathak
Journal:  Angiogenesis       Date:  2011-12-24       Impact factor: 9.596

Review 4.  Genetic and epigenetic events in diabetic wound healing.

Authors:  Haloom Rafehi; Assam El-Osta; Tom C Karagiannis
Journal:  Int Wound J       Date:  2010-12-16       Impact factor: 3.315

5.  Association of Diabetes and Insulin Therapy With Risk of Hospitalization for Infection and 28-Day Mortality Risk.

Authors:  John P Donnelly; Sunil Nair; Russell Griffin; John W Baddley; Monika M Safford; Henry E Wang; Nathan I Shapiro
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

6.  [Topical tacrolimus in necrobiosis lipoidica].

Authors:  D Barth; W Harth; R Treudler; J C Simon
Journal:  Hautarzt       Date:  2011-06       Impact factor: 0.751

7.  Ciprofloxacin inhibits advanced glycation end products-induced adhesion molecule expression on human monocytes.

Authors:  S Mori; H K Takahashi; K Liu; H Wake; J Zhang; R Liu; T Yoshino; M Nishibori
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 8.  Hyperoxia, endothelial progenitor cell mobilization, and diabetic wound healing.

Authors:  Zhao-Jun Liu; Omaida C Velazquez
Journal:  Antioxid Redox Signal       Date:  2008-11       Impact factor: 8.401

9.  Healing of chronic necrobiosis lipoidica lesions in a type 1 diabetic patient after pancreas-kidney transplantation: a case report.

Authors:  D Gullo; A Latina; L Tomaselli; M L Arpi; S Squatrito; S Curatolo; S La Greca; R Vigneri
Journal:  J Endocrinol Invest       Date:  2007-03       Impact factor: 4.256

10.  The association between Solar Lentigines and Type-2 Diabetes.

Authors:  Bobak Moazzami; Niloofar Razavi; Mansour Babaei; Motahareh Haghparast; Mohammad Ali Bayani
Journal:  Caspian J Intern Med       Date:  2017
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.